Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MAPROTILINE vs MAVACAMTEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MAPROTILINE vs MAVACAMTEN: Safety Overview

Metric MAPROTILINE MAVACAMTEN
Total FAERS Reports 209 3,250
Deaths Reported 30 79
Death Rate 14.4% 2.4%
Hospitalizations 119 454
Average Patient Age 58.2 yrs 66.6 yrs
% Female Patients 79.8% 69.1%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 28, 2022
Manufacturer N/A Myokardia, Inc.
Route N/A ORAL
Marketing Status Discontinued Prescription